Phone
ClinicalTrials.gov URL
Acknowledgement
5 business days
EA Page
Myeloid Therapeutics
EA Policies for Single Patient
Myeloid has one product, MT-101, in clinical trials. The trial is a Phase 1 multi-dose ascending trial for safety and tolerability. There is no expanded access to MT-101 until more therapeutic data is obtained.
EA Policies for Disease / Category